[1]Martinez,Ana;Fernandez,Enrique;Castro,Ana;Conde,Santiago;Rodriguez-Franco,Isabel;Baos,Josep-Eladi;Badia,Albert[EuropeanJournalofMedicinalChemistry,2000,vol.35,#10,p.913-922]
[1]Martinez,Ana;Alonso,Mercedes;Castro,Ana;Pérez,Concepción;Moreno,FranciscoJ.[JournalofMedicinalChemistry,2002,vol.45,#6,p.1292-1299]
[2]CurrentPatentAssignee:GOVERNMENTOFSPAIN-US2003/195238,2003,A1Locationinpatent:Page/Pagecolumn5-6
[1]Martinez,Ana;Alonso,Mercedes;Castro,Ana;Pérez,Concepción;Moreno,FranciscoJ.[JournalofMedicinalChemistry,2002,vol.45,#6,p.1292-1299]
[1]Martinez,Ana;Fernandez,Enrique;Castro,Ana;Conde,Santiago;Rodriguez-Franco,Isabel;Baos,Josep-Eladi;Badia,Albert[EuropeanJournalofMedicinalChemistry,2000,vol.35,#10,p.913-922]
[1]Martinez,Ana;Fernandez,Enrique;Castro,Ana;Conde,Santiago;Rodriguez-Franco,Isabel;Baos,Josep-Eladi;Badia,Albert[EuropeanJournalofMedicinalChemistry,2000,vol.35,#10,p.913-922]
Title: Activation of AKT/GSK3β pathway by TDZD-8 attenuates kainic acid induced neurodegeneration but not seizures in mice.
Journal: Neurotoxicology 20150101
Title: Forecasting cell death dose-response from early signal transduction responses in vitro.
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20140801
Title: Attenuation of β-amyloid-induced tauopathy via activation of CK2α/SIRT1: targeting for cilostazol.
Journal: Journal of neuroscience research 20140201
Title: A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Journal: The Biochemical journal 20130415
Title: Bis(12)-hupyridone, a novel acetylcholinesterase inhibitor, protects against glutamate-induced neuronal excitotoxicity via activating α7 nicotinic acetylcholine receptor/phosphoinositide 3-kinase/Akt cascade.
Journal: Chemico-biological interactions 20130325
Title: Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening.
Journal: Bioorganic & medicinal chemistry letters 20121201
Title: Specific deletion of glycogen synthase kinase-3β in the renal proximal tubule protects against acute nephrotoxic injury in mice.
Journal: Kidney international 20121101
Title: Inhibition of glycogen synthase kinase-3β prevents NSAID-induced acute kidney injury.
Journal: Kidney international 20120401
Title: Synergistic interactions between PDE4B and GSK-3: DISC1 mutant mice.
Journal: Neuropharmacology 20120301
Title: Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
Journal: Nature biotechnology 20111101
Title: miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2.
Journal: The Journal of biological chemistry 20111028
Title: Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania.
Journal: The international journal of neuropsychopharmacology 20110901
Title: Increased galectin-3 facilitates leukemia cell survival from apoptotic stimuli.
Journal: Biochemical and biophysical research communications 20110826
Title: Discovery of 1,2,4-thiadiazolidine-3,5-dione analogs that exhibit unusual and selective rapid cell death kinetics against acute myelogenous leukemia cells in culture.
Journal: Bioorganic & medicinal chemistry letters 20110815
Title: Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo.
Journal: The Prostate 20110601
Title: Tumor necrosis factor-α induces increased lung vascular permeability: a role for GSK3α/β.
Journal: European journal of pharmacology 20110425
Title: The anti-tumoral drug enzastaurin inhibits natural killer cell cytotoxicity via activation of glycogen synthase kinase-3β.
Journal: Biochemical pharmacology 20110115
Title: Cdc42-mediated inhibition of GSK-3β improves angio-architecture and lumen formation during VEGF-driven pathological angiogenesis.
Journal: Microvascular research 20110101
Title: Valproic acid inhibits neural progenitor cell death by activation of NF-κB signaling pathway and up-regulation of Bcl-XL.
Journal: Journal of biomedical science 20110101
Title: Imaging pulmonary NF-kappaB activation and therapeutic effects of MLN120B and TDZD-8.
Journal: PloS one 20110101
Title: GSK3beta plays dirty in acute kidney injury.
Journal: Journal of the American Society of Nephrology : JASN 20100201
Title: Inhibition of glycogen synthase kinase 3beta (GSK3beta) decreases inflammatory responses in brain endothelial cells.
Journal: The American journal of pathology 20100201
Title: GSK3beta promotes apoptosis after renal ischemic injury.
Journal: Journal of the American Society of Nephrology : JASN 20100201
Title: Inhibition of nitric oxide (NO) production in lipopolysaccharide (LPS)-activated murine macrophage RAW 264.7 cells by the norsesterterpene peroxide, epimuqubilin A.
Journal: Marine drugs 20100101
Title: Atherosclerosis induced by a high-fat diet is alleviated by lithium chloride via reduction of VCAM expression in ApoE-deficient mice.
Journal: Vascular pharmacology 20100101
Title: Inhibition of glioblastoma growth by the thiadiazolidinone compound TDZD-8.
Journal: PloS one 20100101
Title: Inhibition of glycogen synthase kinase-3β prevents activation of focal adhesion kinase after ischemia/reperfusion of the rat lung.
Journal: Clinical hemorheology and microcirculation 20100101
Title: Yeast glycogen synthase kinase-3beta pathway inhibitors from an organic extract of Streptomyces sp.
Journal: Journal of natural products 20090801
Title: GSK-3beta inhibitor modulates TLR2/NF-kappaB signaling following myocardial ischemia-reperfusion.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20090701
Title: Inhibiting glycogen synthase kinase-3 reduces endotoxaemic acute renal failure by down-regulating inflammation and renal cell apoptosis.
Journal: British journal of pharmacology 20090701
Title: Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta.
Journal: Diabetes 20090101
Title: Growth control of multiple myeloma cells through inhibition of glycogen synthase kinase-3.
Journal: Leukemia & lymphoma 20081001
Title: Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus.
Journal: Shock (Augusta, Ga.) 20080901
Title: Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis.
Journal: Journal of cardiovascular pharmacology 20080901
Title: Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8).
Journal: Blood 20071215
Title: Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte.
Journal: Brain research 20071201
Title: Effects of glycogen synthase kinase-3beta inhibition on the development of cerulein-induced acute pancreatitis in mice.
Journal: Critical care medicine 20071201
Title: Glycogen synthase kinase-3beta inhibition attenuates asthma in mice.
Journal: American journal of respiratory and critical care medicine 20070901
Title: Lithium suppresses cell proliferation by interrupting E2F-DNA interaction and subsequently reducing S-phase gene expression in prostate cancer.
Journal: The Prostate 20070615
Title: Glycogen synthase kinase-3beta inhibition attenuates the development of ischaemia/reperfusion injury of the gut.
Journal: Intensive care medicine 20070501
Title: The leukemic stem cell.
Journal: Best practice & research. Clinical haematology 20070301
Title: Glycogen synthase kinase-3 is required for optimal de novo synthesis of inositol.
Journal: Molecular microbiology 20070201
Title: Glycogen synthase kinase 3beta inhibition reduces the development of nonseptic shock induced by zymosan in mice.
Journal: Shock (Augusta, Ga.) 20070101
Title: Inhibiting glycogen synthase kinase 3beta in sepsis.
Journal: Novartis Foundation symposium 20070101
Title: Involvement of glycogen synthase kinase-3beta in palmitate-induced human umbilical vein endothelial cell apoptosis.
Journal: Journal of vascular research 20070101
Title: Glycogen synthase kinase-3beta inhibition attenuates the development of bleomycin-induced lung injury.
Journal: International journal of immunopathology and pharmacology 20070101
Title: Inhibition of glycogen synthase kinase-3beta attenuates the development of carrageenan-induced lung injury in mice.
Journal: British journal of pharmacology 20061101
Title: Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord trauma.
Journal: The Journal of pharmacology and experimental therapeutics 20060701
Title: Glycogen synthase kinase-3beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse.
Journal: Clinical immunology (Orlando, Fla.) 20060701
Title: Insulin reduces the multiple organ injury and dysfunction caused by coadministration of lipopolysaccharide and peptidoglycan independently of blood glucose: role of glycogen synthase kinase-3beta inhibition.
Journal: Critical care medicine 20060501
Title: Glycogen synthase kinase-3beta inhibitors protect against the organ injury and dysfunction caused by hemorrhage and resuscitation.
Journal: Shock (Augusta, Ga.) 20060501
Title: Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3beta.
Journal: British journal of pharmacology 20060301
Title: The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells.
Journal: Journal of molecular medicine (Berlin, Germany) 20060301
Title: Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle.
Journal: The Journal of pharmacology and experimental therapeutics 20060101
Title: SAR and 3D-QSAR studies on thiadiazolidinone derivatives: exploration of structural requirements for glycogen synthase kinase 3 inhibitors.
Journal: Journal of medicinal chemistry 20051117
Title: Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3beta and PI3K/Akt/mTOR-dependent mechanisms.
Journal: The international journal of biochemistry & cell biology 20051001
Title: GSK-3beta inhibitors reduce protein degradation in muscles from septic rats and in dexamethasone-treated myotubes.
Journal: The international journal of biochemistry & cell biology 20051001
Title: GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat.
Journal: Critical care medicine 20050901
Title: What do insulin, estrogen, valproic acid, and TDZD-8 have in common?
Journal: Critical care medicine 20050901
Title: Protein breakdown in muscle from burned rats is blocked by insulin-like growth factor i and glycogen synthase kinase-3beta inhibitors.
Journal: Endocrinology 20050701
Title: Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20050615
Title: Inhibition of GSK3beta is a common event in neuroprotection by different survival factors.
Journal: Brain research. Molecular brain research 20050613
Title: Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20040701
Title: First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease.
Journal: Journal of medicinal chemistry 20020314
Title: Martinez A, et al. First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease. J Med Chem. 2002 Mar 14;45(6):1292-9.
Title: Xie CL, et al. Inhibition of Glycogen Synthase Kinase-3β (GSK-3β) as potent therapeutic strategy to ameliorates L-dopa-induced dyskinesia in 6-OHDA parkinsonian rats. Sci Rep. 2016 Mar 21;6:23527.
Title: Sun A, et al. GSK-3β controls autophagy by modulating LKB1-AMPK pathway in prostate cancer cells. Prostate. 2016 Feb;76(2):172-83.
